NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/18/2024
Back to search
Official data from USPTO
NEXTWAVE PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEXTWAVE PHARMACEUTICALS
ST13
US500000085406355Class
5
Filing
85406355
Registration
4425993
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
54
Latest update
03/18/2024
Trademark type
Word
Nice classes
5
Filing date
08/24/2011
Registration date
10/29/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/18/2024
Last transaction
03/18/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/31/2013
First use in commerce
01/31/2013
Drawing code
4
Owner type
03
Owner location
Monmouth Junction, NJ
Examiner
LOVELACE, JAMES
Law office
M80
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
N. I. (pessoa física)
N. I. (pessoa física)
Representatives
Cathy A. Kodroff Howson & Howson, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals for the treatment of hypertension; pharmaceuticals for the treatment of attention deficit hyperactivity disorder (ADHD); pharmaceuticals for the treatment of cardiovascular diseases; pharmaceuticals for the treatment of central nervous system diseases
Publications
History of USPTO decisions and trademark events.
54 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/18/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/18/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/18/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
10/13/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/29/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/01/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/01/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/01/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/28/2019
E815
TEAS SECTION 8 & 15 RECEIVED
10/28/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/05/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/05/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/29/2018
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/03/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
10/29/2013
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/26/2013
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
09/25/2013
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/24/2013
EEXT
SOU TEAS EXTENSION RECEIVED
09/23/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/23/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/23/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/23/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/03/2013
GNRT
NON-FINAL ACTION E-MAILED
04/03/2013
CNRT
SU - NON-FINAL ACTION - WRITTEN
04/03/2013
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/21/2013
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/20/2013
EX2G
SOU EXTENSION 2 GRANTED
03/20/2013
IUAF
USE AMENDMENT FILED
03/18/2013
EXT2
SOU EXTENSION 2 FILED
03/18/2013
EEXT
SOU TEAS EXTENSION RECEIVED
03/18/2013
EISU
TEAS STATEMENT OF USE RECEIVED
03/18/2013
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/13/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/13/2012
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/06/2012
EX1G
SOU EXTENSION 1 GRANTED
10/05/2012
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/05/2012
EXT1
SOU EXTENSION 1 FILED
10/03/2012
EEXT
SOU TEAS EXTENSION RECEIVED
10/03/2012
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/03/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/07/2012
PUBO
PUBLISHED FOR OPPOSITION
02/07/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/18/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/05/2012
ALIE
ASSIGNED TO LIE
01/05/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/14/2011
XAEC
EXAMINER'S AMENDMENT ENTERED
12/14/2011
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/14/2011
GNEA
EXAMINERS AMENDMENT E-MAILED
12/14/2011
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/14/2011
DOCK
ASSIGNED TO EXAMINER
12/13/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/30/2011
NWAP
NEW APPLICATION ENTERED
08/27/2011
Continuous trademark protection
Get notified about every new filing that threatens NEXTWAVE PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.